首页> 外文OA文献 >Survival pattern and determinants of survival in adult HIV-infected patients on antiretroviral treatment in Far-western Development Region, Nepal
【2h】

Survival pattern and determinants of survival in adult HIV-infected patients on antiretroviral treatment in Far-western Development Region, Nepal

机译:尼泊尔西部开发区抗逆转录病毒治疗的成人HIV感染患者的生存模式和生存决定因素

摘要

Objective: This study explores the survival pattern and its determinants among adult HIV-infected patients on ART. Methods: This retrospective cohort study included 1024 (51.2% were men) HIV-infected patients aged ≥15 years who started ART between May 15, 2006 and May 15, 2011 in 5 ART centres in Nepal. Follow-up time was calculated from the date of ART initiation to date of death or censoring (loss to follow-up, transferred out, or 15th of November 2011). Mortality rates (per 100 person-years) were calculated. Kaplan-Meier and Cox-regression models were used to estimate survival and explore determinants of mortality. Results: About 12% (83% of them were male) died during follow-up. The mortality rate was 21.9 (16.6- 28.8) within the first 3 months after ART initiation. The survival probability was 94.7% at 3 months and 82.9% at 5 years. The independent determinants of mortality were sex, performance scale, WHO clinical stage, and bodyweight. Higher mortality was significantly associated with bedridden performance status, advanced clinical disease, low bodyweight, and change in ART regimen in male patients; and with active tuberculosis and low bodyweight in female patients.Conclusion: High mortality was observed within the first 3 months of ART initiation. Patients with poor clinical characteristics had higher mortality, especially male. Early initiation of ART should be encouraged in HIV-infected patients.
机译:目的:本研究探讨了成人HIV感染ART患者的生存模式及其决定因素。方法:这项回顾性队列研究包括2006年5月15日至2011年5月15日期间在尼泊尔5个ART中心接受抗病毒治疗的年龄≥15岁的1024例(男性为51.2%)。随访时间是从抗病毒治疗开始至死亡或检查日期(随访损失,转出或2011年11月15日)之间计算的。计算死亡率(每100人年)。 Kaplan-Meier和Cox回归模型用于评估生存率并探讨死亡率的决定因素。结果:随访期间约有12%(其中83%为男性)死亡。开始抗逆转录病毒治疗后的头三个月内,死亡率为21.9(16.6-28.8)。 3个月生存率是94.7%,5年生存率是82.9%。死亡率的独立决定因素是性别,绩效量表,WHO临床分期和体重。较高的死亡率与男性患者卧床不起的状态,晚期临床疾病,低体重和抗逆转录病毒治疗方案显着相关;结论:在接受抗逆转录病毒治疗的头三个月内观察到高死亡率。临床特征较差的患者死亡率较高,尤其是男性。 HIV感染患者应鼓励及早开始抗病毒治疗。

著录项

  • 作者

    Bhatta Laxmi;

  • 作者单位
  • 年度 2012
  • 总页数
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号